F11R and plasma cell myeloma: Alternatively, the treatment of a histone deacetylase inhibitor (HDACi) will be an option because Stiff et al. [51] showed that HDACi induced JAM-A expression and thereby facilitated MRV infection in multiple myeloma cells.